Results 371 to 380 of about 210,353 (388)

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

Current Medical Research and Opinion, 2014
François Laliberté, Craig Coleman
exaly  

Warfarin

2014
openaire   +1 more source

Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF

European Heart Journal Quality of Care & Clinical Outcomes, 2019
Richard C Becker, Scott D Berkowitz, Günter Breithardt   +2 more
exaly  

Interaction between warfarin and cannabis

Basic and Clinical Pharmacology and Toxicology, 2019
Per Damkier, Mette Marie Hougaard Christensen, Maja Hellfritzsch   +2 more
exaly  

Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials

Journal of Thrombosis and Haemostasis, 2015
Chatree Chai-Adisaksopha, Alfonso Iorio
exaly  

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Nature, 2004
Johannes Oldenburg
exaly  

The story of the discovery of heparin and warfarin

British Journal of Haematology, 2008
David M Keeling
exaly  

Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery

Journal of Thrombosis and Haemostasis, 2016
exaly  

Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation

American Journal of Kidney Diseases, 2015
Jenny I Shen, Maria E Montez-Rath, Tara I Chang   +2 more
exaly  

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis

Stroke, 2017
Ying Bai, Hai Deng, A. Shantsila, G. Lip
semanticscholar   +1 more source